- cafead   Apr 26, 2024 at 11:42: AM
via Gilead Sciences on Thursday released its first-quarter 2024 earnings results, touting a 5% year-on-year increase in total revenue, driven by the strong performance of its HIV, cancer and liver disease businesses.
article source
article source